BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20200353)

  • 1. The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells.
    Drube S; Heink S; Walter S; Löhn T; Grusser M; Gerbaulet A; Berod L; Schons J; Dudeck A; Freitag J; Grotha S; Reich D; Rudeschko O; Norgauer J; Hartmann K; Roers A; Kamradt T
    Blood; 2010 May; 115(19):3899-906. PubMed ID: 20200353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kit activates interleukin-4 receptor and effector signal transducer and activator of transcription 6 independent of its cognate ligand in mouse mast cells.
    Sethumadhavan A; Mani M
    Immunology; 2020 Apr; 159(4):441-449. PubMed ID: 31957000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
    Palmer G; Lipsky BP; Smithgall MD; Meininger D; Siu S; Talabot-Ayer D; Gabay C; Smith DE
    Cytokine; 2008 Jun; 42(3):358-64. PubMed ID: 18450470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells.
    Kalesnikoff J; Rios EJ; Chen CC; Nakae S; Zabel BA; Butcher EC; Tsai M; Tam SY; Galli SJ
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2659-64. PubMed ID: 16533754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steel factor-induced tyrosine phosphorylation in murine mast cells. Common elements with IL-3-induced signal transduction pathways.
    Welham MJ; Schrader JW
    J Immunol; 1992 Oct; 149(8):2772-83. PubMed ID: 1383327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Kit controls IL-1β-induced effector functions in HMC-cells.
    Drube S; Schmitz F; Göpfert C; Weber F; Kamradt T
    Eur J Pharmacol; 2012 Jan; 675(1-3):57-62. PubMed ID: 22173128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent.
    Enoksson M; Möller-Westerberg C; Wicher G; Fallon PG; Forsberg-Nilsson K; Lunderius-Andersson C; Nilsson G
    Blood; 2013 Jan; 121(3):530-6. PubMed ID: 23093619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation.
    Lukacs NW; Kunkel SL; Strieter RM; Evanoff HL; Kunkel RG; Key ML; Taub DD
    Blood; 1996 Mar; 87(6):2262-8. PubMed ID: 8630386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells.
    Ali S; Huber M; Kollewe C; Bischoff SC; Falk W; Martin MU
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18660-5. PubMed ID: 18003919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells.
    Ishizuka T; Chayama K; Takeda K; Hamelmann E; Terada N; Keller GM; Johnson GL; Gelfand EW
    J Immunol; 1999 Feb; 162(4):2087-94. PubMed ID: 9973482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase.
    Mirmonsef P; Shelburne CP; Fitzhugh Yeatman C; Chong HJ; Ryan JJ
    J Immunol; 1999 Sep; 163(5):2530-9. PubMed ID: 10452990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.
    Chackerian AA; Oldham ER; Murphy EE; Schmitz J; Pflanz S; Kastelein RA
    J Immunol; 2007 Aug; 179(4):2551-5. PubMed ID: 17675517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3.
    Junttila IS; Watson C; Kummola L; Chen X; Hu-Li J; Guo L; Yagi R; Paul WE
    J Allergy Clin Immunol; 2013 Sep; 132(3):704-712.e10. PubMed ID: 23683462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
    Samayawardhena LA; Hu J; Stein PL; Craig AW
    Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-tyrosine phosphatase alpha regulates stem cell factor-dependent c-Kit activation and migration of mast cells.
    Samayawardhena LA; Pallen CJ
    J Biol Chem; 2008 Oct; 283(43):29175-85. PubMed ID: 18725415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand.
    Mekori YA; Oh CK; Metcalfe DD
    J Immunol; 1993 Oct; 151(7):3775-84. PubMed ID: 7690814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I787 provides signals for c-Kit receptor internalization and functionality that control mast cell survival and development.
    Orinska Z; Föger N; Huber M; Marschall J; Mirghomizadeh F; Du X; Scheller M; Rosenstiel P; Goldmann T; Bollinger A; Beutler BA; Bulfone-Paus S
    Blood; 2010 Oct; 116(15):2665-75. PubMed ID: 20595514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine kinase-deficient Wv c-kit induces mast cell adhesion and chemotaxis.
    Dastych J; Taub D; Hardison MC; Metcalfe DD
    Am J Physiol; 1998 Nov; 275(5):C1291-9. PubMed ID: 9814978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-3 is essential for ICOS-L stabilization on mast cells, and sustains the IL-33-induced RORγt
    Drube S; Müller S; Weber F; Wegner P; Böttcher-Loschinski R; Gaestel M; Hutloff A; Kamradt T; Andreas N
    Immunology; 2021 May; 163(1):86-97. PubMed ID: 33427298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fps/Fes protein-tyrosine kinase regulates mast cell adhesion and migration downstream of Kit and beta1 integrin receptors.
    Smith JA; Samayawardhena LA; Craig AW
    Cell Signal; 2010 Mar; 22(3):427-36. PubMed ID: 19892014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.